Recent study titled, Blood Culture Test Market By Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026 which covers detailed statistical analysis and enlightens market dynamics and trends that provide a holistic picture of the industry.
The global Blood Culture Test Market is estimated to grow at CAGR above 8.5% over the forecast time frame 2019-2026 and reach the market value around USD 6.7 billion by 2026.
Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1338
The most important factor that is expected to boost growth is an increasing prevalence of bloodstream infections and infectious disease. Increasing demand is projected to drive growth for advanced diagnostic techniques of infectious disease diagnosis such as sepsis. Many manufacturers have therefore begun to focus on developing advanced diagnostic tools and consumer goods. For example, Cepheid offers the Xpert MRSA / SA test to help detect SA and MRSA accurately in positive blood culture in approximately 1 hour.
The launch of various government initiatives on infection prevention and control is likely to boost the demand for blood cultivation testing. The Central Lines of Blood Stream Infections in the USA have fallen by 46 per cent from the 2008-2013 period, as a result of the efforts of the US administration in preventing Hospital-acquired Infections (HAIs).
The bacterial infection that spreads to the blood in various diseases such as, osteomyelitis, meningitis, pneumonia, renal infection and sepsis, has been detected through blood culture trials. Fungal and mycobacterial diseases can also be detected. As the most common cause of BSI and other infections is bacterial infections, the bacterial infection segment was leading the sales market in 2018. During the forecast period the segment will also record the highest CAGR.
It is anticipated, in developing countries such as South Africa, Tanzania, China, India and Argentina, that increased awareness of healthcare and health care infrastructures will foster growth for this sector. These countries’ governments are striving to deliver better quality healthcare facilities and diagnostic products that further support adoption. Due to BSI prevalence and an increasing number of cases of septicism worldwide, the fungal infections segment is projected to show profitable growth over a study period. For example, Candida species are the dominant fungal sepsis agents, representing approximately 10 to 15% of infections in health care.
Hospital Laboratories accounted for the prime market share in terms of revenue in 2018
In 2018, the largest market share of revenue was in hospital laboratories. This is because hospital acquired infections (HAIs) are increasingly present. According to the WHO, the rate in developed developing countries is about two to three times greater than in developed countries of ICU infections acquired, such as Urinary Tract Infections (UTIs) and surgical site wound infections. In Canada, approximately 8,000 patients die from hospital infections each year.
Moreover, over the forecast period, the hospital laboratories segment will expand at the fastest CAGR. The main cause of growth is increased health awareness along with government and non-governmental initiatives for the prevention and control of infectious diseases. For instance, CDC collaborated on developing national HIV clinical and research guidelines, supporting HIV and tuberculosis programs and conducting epidemiology training with the Government of South Africa.
View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/blood-culture-test-market
The reference laboratories section is expected to show lucrative growth during the forecast period as blood tests by hospitals are outsourced to the reference laboratories. In addition to the new and advanced diagnostic techniques available in reference laboratories, these are more accurate, reliable and rapid. Other segments of use include academic laboratories, bacteriological labs, pathology laboratories and doctor’s labs. It is also expected, during the forecast period, to increase significantly.
Key Players & Strategies
The Blood Culture Test market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players are Becton, Dickinson and Company; Thermo Fisher Scientific, Inc.; bioMérieux SA; Danaher Corporation; Rohe; BrU.K.er Corporation; and Abbott Laboratories.
Would like to place an order or any question, please feel free to contact at firstname.lastname@example.org | +1 407 915 4157
TABLE OF CONTENT
CHAPTER 1. INDUSTRY OVERVIEW
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
CHAPTER 4. BLOOD CULTURE TEST MARKET BY PRODUCT
CHAPTER 5. BLOOD CULTURE TEST MARKET BY TECHNIQUE
CHAPTER 6. BLOOD CULTURE TEST MARKET BY TECHNOLOGY
CHAPTER 7. BLOOD CULTURE TEST MARKET BY APPLICATION
CHAPTER 8. BLOOD CULTURE TEST MARKET BY END USE
CHAPTER 9. NORTH AMERICA BLOOD CULTURE TEST MARKET BY COUNTRY
CHAPTER 10. EUROPE BLOOD CULTURE TEST MARKET BY COUNTRY
CHAPTER 11. ASIA-PACIFIC BLOOD CULTURE TEST MARKET BY COUNTRY
CHAPTER 12. LATIN AMERICA BLOOD CULTURE TEST MARKET BY COUNTRY
CHAPTER 13. MIDDLE EAST BLOOD CULTURE TEST MARKET BY COUNTRY
CHAPTER 14. AFRICA BLOOD CULTURE TEST MARKET BY COUNTRY
CHAPTER 15. COMPANY PROFILE
CHAPTER 16. RESEARCH APPROACH
The report is readily available and can be dispatched immediately after payment confirmation.
Buy this premium research report – https://www.acumenresearchandconsulting.com/buy-now/0/1338